u/Remarkable-Effect957 · 78d agono track record yet
Helus Pharma (HELP): a broad-label psychedelic, one pivotal readout from a massive re-rating
Helus Pharma's HLP003 pivotal readout (APPROACH trial, mid-November 2026) has an 83% probability of statistical significance with expected 5.2-6 point efficacy in adjunctive MDD, supported by saturated receptor occupancy, favorable Phase 2-to-Phase 3 translation modeling, and FDA guidance alignment. At $13.24, the market prices only ~52% approval probability, while validated benchmarks (Lilly's $2.8bn atai acquisition, J&J's $14.6bn Intra-Cellular purchase) suggest 1.6-5.1× upside.
At post $12.18Now $8.87-27.2% since postedas of Nov 13, 4:45 PM ET
1d—
3d-3.4%
1w+0.3%
1m+3.5%
3m—
6m—
1y—